In the setting of pancreatic cancer, we recently showed that genetic ablation of PAR1 in the pancreatic stroma impeded tumor growth and metastasis [25] suggesting that PAR1 expression contributes to poor prognosis in pancreatic cancer. This evidence concerns the gene F2R and pancreatic neoplasm.